Evolve Proline
Device Trauma & Extremities
PDI 00840420188564
General payments
$375,686
Research payments
$13,600
Through program year 2025, $375,686 in general payments and $13,600 in research payments were reported against Evolve Proline (Trauma & Extremities).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
8 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | General | $68,078 | 79 |
| 2024 | General | $86,691 | 46 |
| 2024 | Research | $500 | 1 |
| 2023 | General | $23,127 | 82 |
| 2023 | Research | $1,600 | 1 |
| 2022 | General | $113,799 | 85 |
| 2022 | Research | $11,500 | 2 |
| 2021 | General | $83,991 | 60 |
Breakdown
The top 5 of 56 recipients; each share is of general payments naming this product in 2025.
The top 5 of 14 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.
The top 5 of 21 states; each share is of general payments naming this product in 2025 where a state was reported.
Records
352 general · 4 researchEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.